3 articles
The Austin-based company is now enrolling participants at the University of Michigan and Massachusetts General Hospital for the Connect-One study, the first clinical trial of a fully implantable BCI designed to restore speech.
The FOCUS-AU trial will test Synchron's advanced brain-computer interface in ten MND patients across three Australian hospitals, with surgery beginning in April.
Kim Han-sol, a blind YouTuber with 1.68 million subscribers, has publicly applied for Neuralink's Blindsight clinical trial, bringing significant public attention to the experimental vision-restoring brain implant.
Get the latest BCI news, breakthroughs, and market moves delivered to your inbox.
No spam. One-click unsubscribe. We respect your privacy.